Lucid Diagnostics Inc. (NASDAQ:LUCD – Free Report) – Equities researchers at Cantor Fitzgerald raised their FY2023 EPS estimates for shares of Lucid Diagnostics in a research report issued on Thursday, August 17th. Cantor Fitzgerald analyst R. Osborn now anticipates that the company will post earnings per share of ($1.14) for the year, up from their […]
Needham & Company LLC Reiterates Buy Rating for Lucid Diagnostics (NASDAQ:LUCD) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Lucid Diagnostics (NASDAQ:LUCD – Get Free Report) is scheduled to be announcing its earnings results before the market opens on Tuesday, August 15th. Investors that are interested in participating in the company’s conference call can do so using this link. Lucid Diagnostics (NASDAQ:LUCD – Get Free Report) last announced its quarterly earnings results on Monday, […]
Lucid Diagnostics Inc. (NASDAQ:LUCD – Get Free Report) saw a significant increase in short interest in the month of June. As of June 30th, there was short interest totalling 149,900 shares, an increase of 5.6% from the June 15th total of 141,900 shares. Approximately 1.5% of the company’s shares are sold short. Based on an […]
Lucid Diagnostics Inc. (NASDAQ:LUCD – Free Report) was the recipient of a significant growth in short interest in June. As of June 15th, there was short interest totalling 141,900 shares, a growth of 21.8% from the May 31st total of 116,500 shares. Based on an average daily volume of 65,800 shares, the short-interest ratio is […]